1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Protein C Inhibitor
(
- Contribution to journal › Article
-
Mark
Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B
(
- Contribution to journal › Article
-
Mark
beta(2)-Glycoprotein I: a novel component of innate immunity
(
- Contribution to journal › Article
- 2010
-
Mark
beta(2)-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome
(
- Contribution to journal › Article
- 2009
-
Mark
Activation of TAFI on the Surface of Streptococcus pyogenes Evokes Inflammatory Reactions by Modulating the Kallikrein/Kinin System
(
- Contribution to journal › Article
-
Mark
The effects of hyperglycaemia on thrombin-activatable fibrinolysis inhibitor
(
- Contribution to journal › Article
-
Mark
Protein C inhibitor--a novel antimicrobial agent.
(
- Contribution to journal › Article
- 2008
-
Mark
The antibacterial activity of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenes.
(
- Contribution to journal › Article
- 2007
-
Mark
Thrombin activatable fibrinolysis inhibitor binds to Streptococcus pyogenes by interacting with collagen-like surface proteins A and B.
(
- Contribution to journal › Article